pembrolizumab
merck
['pembro', 'esophageal', 'gastroesophageal']
. s dr. weijing sun is discussing the phase ii study of perioperative mfolfox plus pembrolizumab combination in patients with potentially resectable adenocarcinoma of the esophageal, gastroesophageal junction (gej) and stomach. #asco22 
We are transforming cancer research and clinical care by linking our innovative approach to drug discovery, delivery and development to our patient care program